Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia-Reference-Cited by-同舟云学术

Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia

Published:2014-05-14 Issue:18 Volume:311 Page:1870
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Robinson Jennifer G.¹,Nedergaard Bettina S.²,Rogers William J.³,Fialkow Jonathan⁴,Neutel Joel M.⁵,Ramstad David⁶,Somaratne Ransi⁷,Legg Jason C.⁷,Nelson Patric⁷,Scott Rob⁷,Wasserman Scott M.⁷,Weiss Robert⁸

Affiliation:

1. Department of Epidemiology, College of Public Health, University of Iowa, Iowa City2Department of Medicine, College of Public Health, University of Iowa, Iowa City

2. Center for Clinical and Basic Research, Aalborg, Denmark

3. Division of Cardiovascular Disease, University of Alabama Medical Center, Birmingham

4. Department of Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami

5. Orange County Research Center, Tustin, California

6. Hampton Roads Center for Clinical Research, Suffolk, Virginia

7. Amgen Inc, Thousand Oaks, California

8. Maine Research Associates, Auburn

Publisher

American Medical Association (AMA)

Subject

General Medicine

Cited by 420 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Efficacy and Tolerability of PCSK9 Targeted Therapy: A Review of the Literature;Drugs;2024-01-25

2. Model-Informed Dose Selection for a Novel Human Immunoglobulin G4 Derived Monoclonal Antibody Targeting Proprotein Convertase Kwashiorkor Type 9: Insights from Population Pharmacokinetics–Pharmacodynamics and Systems Pharmacology;ACS Pharmacology & Translational Science;2024-01-17

3. PCSK9 inhibitors: current status and emerging frontiers in lipid control;Expert Review of Cardiovascular Therapy;2023-11-23

4. Efficacy and Safety of Inclisiran in Asian Patients;JACC: Asia;2023-11

5. First clinical experiences with inclisiran in a real-world setting;Journal of Clinical Lipidology;2023-11